Randomized trial · people
HGH: weekly Pegpesen matched daily rhGH on growth in children
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In children with GHD, a once-weekly pegylated growth hormone kept pace with daily shots on first-year growth, with similar safety.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 391
- Published
- 2025
- Journal
- J Clin Endocrinol Metab
What they tested
The team tested whether Pegpesen, a once-weekly long-acting form of growth hormone, works as well and is as safe as daily growth hormone shots in children with growth hormone deficiency (GHD).
How the study was done
A randomized, controlled phase 3 trial at 23 centers in China in 391 children with GHD, assigned 2:1 to weekly Pegpesen (140 μg/kg/week) or daily rhGH, a lab-made human growth hormone (245 μg/kg/week), for 52 weeks.

What they found
At 52 weeks, growth velocity (how fast a child grows in height per year) was 9.910 cm/year with weekly Pegpesen and 10.037 cm/year with daily rhGH. The gap between groups was -0.127 (95% CI, -0.4868 to 0.2332), which met the trial's test for noninferiority, meaning the weekly shot was not meaningfully worse. Changes in height scores compared with children of the same age and the same bone age showed no significant difference between the groups. Safety and how well children stuck to treatment were also comparable.
What it doesn’t show
The trial lasted 52 weeks and was run only in China, so it doesn't show effects on final adult height or longer-term safety. It tested children with GHD, not adults or other uses of growth hormone.
The paper
Liang et al. A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency. J Clin Endocrinol Metab. 2025.
The compound
More studies on HGH
- HGH: long-acting PEG form beat daily HGH on height at 12 monthsMeta-analysis · people · 2025
- HGH: adult burn wounds healed 9.07 days faster in a meta-analysisMeta-analysis · people · 2014
- HGH: 9.78 cm/year growth vs 10.10 on weekly somatrogonRandomized trial · people · 2022
- HGH: weekly somatrogon 9.65 vs daily 7.87 cm/year in GHD childrenRandomized trial · people · 2022
- HGH: liver fat 3.3% lower at 24 weeks vs no treatment, not significantRandomized trial · people · 2021
- HGH: MoCA cognition score rose from 16.31 to 21.19 after strokeRandomized trial · people · 2020
- Every study on HGH
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.